B

안국약품

001540KOSDAQ

59.5 / 100

Reference Date: 2026-09-08

Financial Score26.0 / 40
News Sentiment17.5 / 25
Momentum6.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health and PBR is significantly undervalued vs. peers is also solid. Plunged 18.8% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

AnKook Pharmaceuticals, established in 1959, is a company specializing in the production and sale of pharmaceuticals and health functional foods, with key products including Sinechura and Levotension. In 2022, sales increased by 16% year-on-year to 271.1 billion KRW, and operating profit rose 32.4% to 6.7 billion KRW, driven by strong market share in respiratory and circulatory drug segments. The company is expanding into AI medical devices and online sales through 'Ewonther' to diversify its business.

Number of Employees

424people

Average Salary

58.6M KRW

Score Calculation Basis

Detailed Financial Score

PER
15.93Industry Average 15.003.0Point

Higher than industry avg (caution)

PBR
0.82Industry Average 1.205.5Point

Lower than industry avg (good)

ROE
4.42Industry Average 8.002.5Point

Below industry avg

Debt Ratio
37.13Industry Average 100.006.5Point

Half of industry avg (excellent)

Trend 2023~20258.5 / 10 points
Revenue Growth Rate
2.5 / 3

Avg ▲14.6% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲39.5% (2-year basis)

ROE Trend
3.0 / 4

Avg ROE 5.1% (improving, 3yr)

Detailed News Sentiment

6 totalPositive 3Neutral 2Negative 1Average Sentiment Score 70

Detailed Momentum

52-week position5.0Point

52w mid range (53%)

Current 10,480Won52-week high 13,25052-week low 7,280
1-month return0.0Point

1m -18.82% (strong drop)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0
  • Neutral반기보고서 (2026.06)2026-08-14